Pistorius L R, Sweidan W H, Purdie D W, Steel S A, Howey S, Bennett J R, Sutton D R
Department of Nuclear Medicine, Princess Royal Hospital, Kingston Upon Hull.
Gut. 1995 Nov;37(5):639-42. doi: 10.1136/gut.37.5.639.
A cross sectional study was undertaken to examine the relationship between coeliac disease and bone mineral density. The 135 female coeliac patients registered on the database of the Department of Gastroenterology at Hull Royal Infirmary were approached by letter, advising them of a potential risk of osteoporosis and inviting them to undergo bone densitometry. A total of 81 registered women (60%) attended the Osteoporosis Laboratory, Princess Royal Hospital and underwent dual energy x ray absorptiometry at the lumbar spine (L2-L4) and femoral neck. Historical data relating to the time of diagnosis and adherence to a gluten free diet were obtained. A control group was selected from the local normal population and was first matched for height, weight, and menopausal status. Postmenopausal patients were then further matched to controls of equivalent menopausal age. In coeliac patients, bone mineral density expressed in g/cm2 as mean (SD) was significantly lower at the lumbar spine (1.076 (0.186)) than in the control group (1.155 (0.143), p < 0.001). This was also the case at the femoral neck (0.887 (0.142) versus 0.965 (0.127), p < 0.001). When the coeliac patients were stratified by menopausal status, it was found that femoral neck bone mineral density was significantly below control values in both premenopausal and postmenopausal women. Spinal bone mineral density exhibited a significant decrement only in the postmenopausal group. The age at diagnosis of coeliac disease and adherence to a gluten free diet did not influence bone mineral density at either hip or spine. These results confirm coeliac patients' higher risk of osteopenia. Coeliac disease should be added to the list of medical conditions which constitute an indication for bone densitometry in order that the individual risk of osteoporosis related fracture may be determined.
开展了一项横断面研究,以检验乳糜泻与骨密度之间的关系。通过信件联系了赫尔皇家医院胃肠病科数据库中登记的135名女性乳糜泻患者,告知她们骨质疏松的潜在风险,并邀请她们接受骨密度测定。共有81名登记女性(60%)前往皇家公主医院骨质疏松实验室,在腰椎(L2-L4)和股骨颈进行了双能X线吸收测定。获取了与诊断时间和坚持无麸质饮食相关的历史数据。从当地正常人群中选取了一个对照组,首先根据身高、体重和绝经状态进行匹配。然后,绝经后患者进一步与绝经年龄相当的对照组进行匹配。在乳糜泻患者中,以g/cm2表示的腰椎骨密度均值(标准差)为1.076(0.186),显著低于对照组(1.155(0.143),p<0.001)。股骨颈的情况也是如此(0.887(0.142)对0.965(0.127),p<0.001)。当根据绝经状态对乳糜泻患者进行分层时,发现绝经前和绝经后女性的股骨颈骨密度均显著低于对照值。仅绝经后组的脊柱骨密度出现显著下降。乳糜泻的诊断年龄和坚持无麸质饮食均未影响髋部或脊柱的骨密度。这些结果证实了乳糜泻患者骨质疏松风险较高。乳糜泻应被列入构成骨密度测定指征的疾病清单中,以便确定个体骨质疏松相关骨折的风险。